-
HEALTH CARE AND BROADER SOCIETAL COSTS OF ADHD IN CANADA ARE SUBSTANTIALLY HIGHER THAN EXPECTED
Aug 11, 2026, 17:16 PM -
COMPARING THE IMPLEMENTATION OF OUTCOMES-BASED AGREEMENTS IN SPAIN AND DENMARK: IMPLICATIONS FOR MANAGING UNCERTAINTY IN EUROPEAN MARKETS
Aug 11, 2026, 17:16 PM -
DIRECT HEALTHCARE COSTS ATTRIBUTABLE TO OBESITY-RELATED COMORBIDITIES IN THE FEDERATION OF BOSNIA AND HERZEGOVINA
Aug 11, 2026, 17:16 PM -
THE FIRST COST-EFFECTIVENESS ANALYSIS OF DOXECITINE AND DOXRIBTIMINE FOR THE TREATMENT OF THYMIDINE KINASE 2 DEFICIENCY (TK2D)
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE OF PEOPLE LIVING WITH PROSTATE IN GREATER ACCRA REGION
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AMONG ADULTS WITH INFLUENZA BY AGE AND COMORBIDITY BURDEN: MULTICENTER REAL-WORLD DATA FROM TURKIYE (2016-2019)
Aug 11, 2026, 17:16 PM -
DOES THE COMMUNITY LIVING ROOM PROGRAMME IMPROVE PHYSICAL HEALTH AMONG SUBDIVIDED UNIT RESIDENTS? A LONGITUDINAL OBSERVATIONAL STUDY IN HONG KONG
Aug 11, 2026, 17:16 PM -
HUMAN PAPILLOMAVIRUS (HPV) VACCINATION COVERAGE AMONG FRENCH ADOLESCENTS AND CONTRIBUTION OF COMMUNITY PHARMACIST: PAPILLON STUDY
Aug 11, 2026, 17:16 PM -
AN EXPLORATION INTO PREDICTORS OF SUSTAINED ENGAGEMENT IN THE COLLECTION OF DIGITAL HEALTH OUTCOMES
Aug 11, 2026, 17:16 PM -
TRENDS IN HEALTH TECHNOLOGY ASSESSMENT SUBMISSION TIMELINES IN IRELAND: A THREE-YEAR RETROSPECTIVE ANALYSIS ACROSS THERAPEUTIC AREAS
Aug 11, 2026, 17:16 PM -
AN ECONOMIC MODEL OF CATUMAXOMAB FOR MALIGNANT ASCITES IN ENGLAND
Aug 11, 2026, 17:16 PM -
TRENDS AND GEOGRAPHIC VARIATION IN PEMBROLIZUMAB COSTS AMONG PRIVATELY INSURED CANCER PATIENTS IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
DOES YOUR REGULATORY PATHWAY UNDERMINE YOUR JCA? SCENARIO PLANNING FOR EVIDENCE GENERATION
Aug 11, 2026, 17:16 PM -
EVALUATING THE ROLE AND APPLICATION OF REAL-WORLD EVIDENCE IN NICE ONCOLOGY HEALTH TECHNOLOGY APPRAISALS AND ITS INFLUENCE ON HTA OUTCOMES (2016-2025)
Aug 11, 2026, 17:16 PM -
HEALTH UTILITY VALUES MEASURED BY EQ-5D IN PATIENTS WITH POST-STROKE HEMIPLGIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
INTEGRATING PATIENT-REPORTED OUTCOMES INTO THE NATIONAL CLINICAL QUALITY FRAMEWORK IN TURKIYE: OPPORTUNITIES FOR EQ-5D
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUE OF DIRECT-ACTING ANTIVIRAL THERAPIES FOR HEPATITIS C IN ASIA- A SYSTEMATIC REVIEW WITH EVIDENCE GAP ANALYSIS
Aug 11, 2026, 17:16 PM -
IMPROVING IDENTIFICATION OF PATIENTS ELIGIBLE FOR ENDOGENOUS CUSHING DISEASE TREATMENT THROUGH CLINICAL EXPERTISE AND MACHINE LEARNING
Aug 11, 2026, 17:16 PM -
SYSTEMATIC SCREENING FOR TYPE 2 DIABETES IN AT-RISK INDIVIDUALS: A MARKOV COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS IN FRANCE
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF LUNG CANCER THERAPIES ASSESSED BY THE FRENCH HTA AGENCY (HAS): A REVIEW OF 20 HTA SUBMISSIONS (2015-2026)
Aug 11, 2026, 17:16 PM
